TD-6424, a rapidly bactericidal agent with multiple mechanisms of action, is more potent in vitro and more rapidly bactericidal than currently available agents against methicillin-susceptible and methicillin-resistant Staphylococcus aureus. TD-6424 produces a postantibiotic effect with a duration of 4 to 6 h against these organisms. The results suggest potential efficacy against susceptible and resistant strains of S. aureus.
CFU/ml of log-phase cultures. At regular intervals, bacteria were enumerated by plate counting from 200 l samples. For both MBC and time-kill assays, bactericidal activity was defined as a Ն3-log 10 decrease in the number of CFU per milliliter within 24 h. The limit of detection was 10 CFU/ml.
The durations of the PAEs were determined according to a published protocol (1) with the following modifications. In brief, the 20-ml starting inoculum of ϳ10 6 CFU/ml was exposed to the MIC of the compound for 1 h at 37°C. Bacteria were then removed from the antibiotic-containing medium by centrifugation and washed with saline to remove residual antibiotic. Bacteria were resuspended in 20 ml of prewarmed Mueller-Hinton broth and incubated with shaking. Plate counts were performed from 100-l samples diluted appropriately at hourly intervals to determine the time at which a 1-log 10 increase in CFU per milliliter occurred after antibiotic removal. The duration of PAE was calculated as the number of hours until return to log-phase growth of treated bacteria minus the time for return of control bacteria (no antibiotic but treated identically) to log-phase growth.
Susceptibility testing. TD-6424 was highly active against MSSA. The MICs of TD-6424 for these organisms were generally lower than those of vancomycin, oxacillin, linezolid, and teicoplanin ( Table 1 ). The MICs of TD-6424 for 47 strains of MSSA ranged from 0.12 to 2 g/ml, and the MIC at which 90% of organisms were inhibited (MIC 90 ) was 1 g/ml. The MIC of TD-6424 for ATCC 13709 was 0.5 g/ml, compared to 0.5 g/ml for nafcillin, gentamicin, and oxacillin, 1 g/ml for vancomycin and teicoplanin, and 4 g/ml for linezolid. TD-6424 was more active against MRSA than were vancomycin, oxacillin, linezolid, and teicoplanin ( Table 1 ). The MICs of TD-6424 for 128 strains of MRSA ranged from Յ0.06 to 2 g/ml, and the MIC 90 was 1 g/ml. The MIC of TD-6424 for ATCC 33591 was 0.5 g/ml, compared to 1 g/ml for vancomycin, 2 g/ml for teicoplanin, linezolid, and gentamicin, and 128 g/ml for nafcillin and oxacillin. TD-6424 (MIC 2 g/ml) was more active than vancomycin, teicoplanin, nafcillin, and oxacillin (all MICs, 8 g/ml) against a well-characterized strain of GISA (HIP 5836). Bactericidal activity. The MBCs of TD-6424 for MSSA (ATCC 13709), MRSA (ATCC 33591), and GISA (HIP 5836) were 2, 4, and 4 g/ml, respectively; the corresponding values for vancomycin were 2, 4, and 8 g/ml, and those for nafcillin were 0.5, Ͼ128, and 128 g/ml. The results of time-kill assays demonstrated the rapid, concentration-dependent bactericidal activity of TD-6424. Results for MSSA indicated that TD-6424 (4 g/ml) reduced the initial inoculum from log 10 6.22 Ϯ 0.08 CFU/ml to log 10 3.36 Ϯ 0.28 CFU/ml within 4 h after administration (Fig. 1A) . Generally, similar results were obtained for nafcillin (4 g/ml). With vancomycin (4 g/ml), the initial inoculum was decreased by only about 1 log 10 at 4 h. Linezolid (8 g/ml) exhibited the least bactericidal activity in this assay. Results with TD-6424 for MRSA were generally similar to those for MSSA (Fig. 1B) : TD-6424 at 8 and 32 g/ml reduced the initial inoculum from log 10 6.05 Ϯ 0.08 CFU/ml to log 10 4.87 Ϯ 0.05 and 1.26 Ϯ 0.26 CFU/ml, respectively, within 4 h. Vancomycin at 8 g/ml exhibited much slower bactericidal activity, and linezolid at 16 g/ml had almost no bactericidal activity against this organism. TD-6424 at 8, 16, and 32 g/ml was also rapidly bactericidal against GISA (Fig. 1C) . By 4 h, the 8-and 32-g/ml concentrations had reduced the initial inoculum from log 10 5.76 Ϯ 0.07 to 3.21 Ϯ 0.12 and 0.98 Ϯ 0.02 CFU/ml, respectively. Linezolid at 8 g/ml reduced the initial inoculum from log 10 5.76 Ϯ 0.07 CFU/ml to log 10 2.73 Ϯ 0.08 CFU/ml by 4 h, and vancomycin at 32 g/ml decreased it from log 10 5.76 Ϯ 0.07 CFU/ml to log 10 4.82 Ϯ 0.02 CFU/ml over this period.
PAE. TD-6424 had long durations (Ն4 h) of PAE against MSSA, MRSA, and GISA (Table 2) . Vancomycin had substantially shorter PAEs, whereas nafcillin did not generate a PAE against the MSSA strain in this assay.
In summary, TD-6424 is highly active against MSSA, MRSA, and GISA and has significant bactericidal activity and a long PAE against these organisms. The in vitro properties of TD-6424 suggest that it may be effective in infections caused by both susceptible and resistant strains of S. aureus. 
